For instance, the FAERS tool used for detecting post-marketing safety signals relies on spontaneous reporting, which may not always provide data of the highest quality
Ready for follow-ups, protein-forward eating, hydration (6480 oz/day), and sleep support
The oral option may ultimately be the more transformative contribution, but CagriSema will likely reach the market first
What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge Editorial Note This brief was updated on May 11, 2026 to reflect changes in the Trump administrations plans for implementation of the BALANCE Model in Medicare and an extension of the Medicare GLP-1 Bridge program through 2027
If you are comparing cost and access, read our guide to affordable tirzepatide and our breakdown of weight loss injection costs
A dose that produces an effect in a mouse does not scale linearly to a human by body weight, and the research doses in this protocol are practitioner-derived conventions, not figures validated against human outcomes